Ceftriaxone & Sulbactam for Injection IP – Zonium -SB 1.5 gm Injection

Ceftriaxone & Sulbactam for Injection IP – Beta-Lactam Protection Against Resistant Pathogens.

Zonium SB 1.5 gm Injection: The Dual composition of Ceftriaxone-1000mg + Sulbactam-500mg injection pairs Ceftriaxone, a third-generation cephalosporin, with Sulbactam, a beta-lactamase inhibitor. Together, they combat various pathogens, including ESBL-producing E. coli and Klebsiella. The dual mechanism ensures sustained efficacy even in complicated infections. Giving IV or IM provides excellent bioavailability and tissue penetration.

Recommended By Specialists:
Pulmonologists prefer treating the disease associated with severe respiratory tract infections, such as community-acquired or hospital-acquired pneumonia.
Urologists: It is preferred to treat the disease associated with complicated urinary tract infections (UTIs) that do not respond to more common antibiotics.
Critical Care Specialists: It is preferred to treat the disease associated with managing critically ill patients who may have severe infections like sepsis or meningitis

Key benefits of Ceftriaxone & Sulbactam for Injection IP – Zonium -SB 1.5 gm Injection:
Cost-Effective Alternative: offers a cost-effective alternative to other β-lactam/β-lactamase inhibitor combinations, providing broad-spectrum antibacterial activity
Enhanced efficacy against pathogens : acts as a β-lactamase inhibitor protecting from enzymatic degradation by resistant bacteria and restores and extends the antibiotic’s activity against β-lactamase-producing organisms, including strains of Acinetobacter baumannii .
Suitable for appropriate use: offering flexibility in treating infections across different age groups.

INDICATIONS:
Bacterial infections
Lower Respiratory Tract Infections
Urinary Tract Infections